167 related articles for article (PubMed ID: 37311985)
1. PFKFB2 is a favorable prognostic biomarker for colorectal cancer by suppressing metastasis and tumor glycolysis.
Liu F; Wei X; Chen Z; Chen Y; Hu P; Jin Y
J Cancer Res Clin Oncol; 2023 Sep; 149(12):10737-10752. PubMed ID: 37311985
[TBL] [Abstract][Full Text] [Related]
2. Knockdown circZNF131 Inhibits Cell Progression and Glycolysis in Gastric Cancer Through miR-186-5p/PFKFB2 Axis.
Shen X; Zhu X; Hu P; Ji T; Qin Y; Zhu J
Biochem Genet; 2022 Oct; 60(5):1567-1584. PubMed ID: 35059934
[TBL] [Abstract][Full Text] [Related]
3. Shikonin inhibits the Warburg effect, cell proliferation, invasion and migration by downregulating PFKFB2 expression in lung cancer.
Sha L; Lv Z; Liu Y; Zhang Y; Sui X; Wang T; Zhang H
Mol Med Rep; 2021 Aug; 24(2):. PubMed ID: 34109434
[TBL] [Abstract][Full Text] [Related]
4. Triptolide restrains the growth, invasion, stemness, and glycolysis of non-small cell lung cancer cells by PFKFB2-mediated PI3K/AKT pathway.
Ren J; Zhao S; Lai J
Chem Biol Drug Des; 2024 Jan; 103(1):e14450. PubMed ID: 38230789
[TBL] [Abstract][Full Text] [Related]
5. miR-613 inhibits Warburg effect in gastric cancer by targeting PFKFB2.
Liu H; Chen K; Wang L; Zeng X; Huang Z; Li M; Dong P; Chen X
Biochem Biophys Res Commun; 2019 Jul; 515(1):37-43. PubMed ID: 31122697
[TBL] [Abstract][Full Text] [Related]
6. miR-21-5p inhibits the growth of brain glioma cells through regulating the glycolysis mediated by PFKFB2.
Zhang L; Liu J
Funct Integr Genomics; 2023 Oct; 23(4):322. PubMed ID: 37864733
[TBL] [Abstract][Full Text] [Related]
7. Forkhead Box S1 mediates epithelial-mesenchymal transition through the Wnt/β-catenin signaling pathway to regulate colorectal cancer progression.
Zhang L; Ren CF; Yang Z; Gong LB; Wang C; Feng M; Guan WX
J Transl Med; 2022 Jul; 20(1):327. PubMed ID: 35864528
[TBL] [Abstract][Full Text] [Related]
8.
Cheng C; Huang Z; Zhou R; An H; Cao G; Ye J; Huang C; Wu D
Am J Physiol Gastrointest Liver Physiol; 2020 May; 318(5):G841-G853. PubMed ID: 32146835
[TBL] [Abstract][Full Text] [Related]
9. SPP1, analyzed by bioinformatics methods, promotes the metastasis in colorectal cancer by activating EMT pathway.
Xu C; Sun L; Jiang C; Zhou H; Gu L; Liu Y; Xu Q
Biomed Pharmacother; 2017 Jul; 91():1167-1177. PubMed ID: 28531945
[TBL] [Abstract][Full Text] [Related]
10. STIP1 knockdown suppresses colorectal cancer cell proliferation, migration and invasion by inhibiting STAT3 pathway.
Xia Y; Chen J; Liu G; Huang W; Wei X; Wei Z; He Y
Chem Biol Interact; 2021 May; 341():109446. PubMed ID: 33766539
[TBL] [Abstract][Full Text] [Related]
11. Low glucose enhanced metformin's inhibitory effect on pancreatic cancer cells by suppressing glycolysis and inducing energy stress via up-regulation of miR-210-5p.
Ma M; Ma C; Li P; Ma C; Ping F; Li W; Xu L; Zhang H; Sun Q; Li Y
Cell Cycle; 2020 Sep; 19(17):2168-2181. PubMed ID: 32718270
[TBL] [Abstract][Full Text] [Related]
12. Upregulated NNT-AS1, a long noncoding RNA, contributes to proliferation and migration of colorectal cancer cells in vitro and in vivo.
Wang Q; Yang L; Hu X; Jiang Y; Hu Y; Liu Z; Liu J; Wen T; Ma Y; An G; Feng G
Oncotarget; 2017 Jan; 8(2):3441-3453. PubMed ID: 27966450
[TBL] [Abstract][Full Text] [Related]
13. CDX2 as a Predictive Biomarker Involved in Immunotherapy Response Suppresses Metastasis through EMT in Colorectal Cancer.
Wang YS; Kou Y; Zhu RT; Han BW; Li CH; Wang HJ; Wu HB; Xia TM; Che XM
Dis Markers; 2022; 2022():9025668. PubMed ID: 36277982
[TBL] [Abstract][Full Text] [Related]
14. Overexpression of long non-coding RNA-CTD903 inhibits colorectal cancer invasion and migration by repressing Wnt/β-catenin signaling and predicts favorable prognosis.
Yuan Z; Yu X; Ni B; Chen D; Yang Z; Huang J; Wang J; Chen D; Wang L
Int J Oncol; 2016 Jun; 48(6):2675-85. PubMed ID: 27035092
[TBL] [Abstract][Full Text] [Related]
15. 6-Phosphofructo-2-Kinase/Fructose-2,6-Biphosphatase-2 Regulates TP53-Dependent Paclitaxel Sensitivity in Ovarian and Breast Cancers.
Yang H; Shu Z; Jiang Y; Mao W; Pang L; Redwood A; Jeter-Jones SL; Jennings NB; Ornelas A; Zhou J; Rodriguez-Aguayo C; Bartholomeusz G; Iles LR; Zacharias NM; Millward SW; Lopez-Berestein G; Le XF; Ahmed AA; Piwnica-Worms H; Sood AK; Bast RC; Lu Z
Clin Cancer Res; 2019 Sep; 25(18):5702-5716. PubMed ID: 31391192
[TBL] [Abstract][Full Text] [Related]
16. Long intergenic non-protein coding RNA 115 (LINC00115) aggravates retinoblastoma progression by targeting microRNA miR-489-3p that downregulates 6-phosphofructo-2-kinase/fructose-2,6-biphosphatase 2 (PFKFB2).
Ji F; Dai C; Xin M; Zhang J; Zhang Y; Liu S
Bioengineered; 2022 Mar; 13(3):5330-5343. PubMed ID: 35184643
[TBL] [Abstract][Full Text] [Related]
17. LncRNA TUG1 promoted KIAA1199 expression via miR-600 to accelerate cell metastasis and epithelial-mesenchymal transition in colorectal cancer.
Sun J; Hu J; Wang G; Yang Z; Zhao C; Zhang X; Wang J
J Exp Clin Cancer Res; 2018 May; 37(1):106. PubMed ID: 29776371
[TBL] [Abstract][Full Text] [Related]
18. Oncogene FOXK1 enhances invasion of colorectal carcinoma by inducing epithelial-mesenchymal transition.
Wu Y; Peng Y; Wu M; Zhang W; Zhang M; Xie R; Zhang P; Bai Y; Zhao J; Li A; Nan Q; Chen Y; Ren Y; Liu S; Wang J
Oncotarget; 2016 Aug; 7(32):51150-51162. PubMed ID: 27223064
[TBL] [Abstract][Full Text] [Related]
19. Downregulation of SLC9A8 Promotes Epithelial-Mesenchymal Transition and Metastasis in Colorectal Cancer Cells via the IL6-JAK1/STAT3 Signaling Pathway.
Liu W; Geng C; Li X; Li Y; Song S; Wang C
Dig Dis Sci; 2023 May; 68(5):1873-1884. PubMed ID: 36583805
[TBL] [Abstract][Full Text] [Related]
20. Topoisomerase IIβ binding protein 1 serves as a novel prognostic biomarker for stage II-III colorectal cancer patients.
Wang Y; Yan X; Qu X; Mao J; Wang J; Yang M; Tao M
Pathol Res Pract; 2023 Jan; 241():154287. PubMed ID: 36586311
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
